Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: Lack of a role of cytotoxin- associated protein A-positive strains and absence of a systemic inflammatory response

Circulation

Volumn 100, Issue 23, 1999, Pages 2326-2331

  Koenig, Wolfgang ^a   Rothenbacher, Dietrich ^b   Hoffmeister, Albrecht ^a   Miller, Markus ^a   Bode, Guenther ^a   Adler, Guido ^a   Hombach, Vinzenz ^a   März, Winfried ^c   Pepys, Mark B ^d   Brenner, Hermann ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Antibodies; Coronary disease; Helicobacter pylori; Risk factors

Indexed keywords

CYTOTOXIN; IMMUNOGLOBULIN G ANTIBODY; PROTEIN A;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL VIRULENCE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033534057     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.23.2326     Document Type: Article

References (19)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-436.
2. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart. 1996;75:568-572.
3. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ. 1997;314:317-318.
4. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997;315:1199-1201.
5. Folsom AR, Nieto JF, Sorlie P, Chambless LE, Graham DY, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation. 1998;98:845-850.
6. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JWG, Sweetnam PM, Elwood PC. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation. 1998;98:1286-1290.
7. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ. 1998;316: 1130-1132.
8. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279: 1477-1482.
9. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation. 1998;97:1675-1679.
10. + Helicobacter pylori strains. Lab Invest. 1995;71:760-770.
11. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766-2769.
12. 13C-urea breath test for identification of Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1997;9:1085-1089.
13. SAS Language: Reference 6. 1st ed. Cary, NC: SAS Institute Inc; 1990.
14. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, Massone A, Papini E, Xiang Z, Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993; 90:5791-5795.
15. Munro JM, Cotron RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest. 1988;58:249-261.
16. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
17. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-4103.
18. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97:1671-1674. Editorial.
19. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol. 1998;31:1217-1225.